RHEUMATOLOGY

A time for action: Opportunities for preventing the growing burden and disability from musculoskeletal conditions in low- and middle-income countries

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on A time for action: Opportunities for preventing the growing burden and disability from musculoskeletal conditions in low- and middle-income countries

Abstract Musculoskeletal (MSK) conditions cause an enormous global burden, and this is dramatically increasing in developing countries, particularly due to rapidly ageing populations and increasing obesity. Many of the global…

read more

Inhibitors of angiogenesis: Ready for prime time?

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Inhibitors of angiogenesis: Ready for prime time?

Abstract Angiogenesis plays a crucial role in the pathogenesis of inflammatory diseases, including rheumatoid arthritis (RA). Therefore, targeting neovascularization in RA may hold great therapeutic potential. Several mediating factors are…

read more

Mesenchymal stromal cells for treatment of arthritis

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Mesenchymal stromal cells for treatment of arthritis

Abstract Patients with refractory inflammatory arthritis can still respond favourable to autologous haematopoietic stem cell transplantation. However, this treatment has a high morbidity and even 5% mortality. Mesenchymal stromal cells…

read more

Epigenetic changes: The missing link

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Epigenetic changes: The missing link

Abstract The association of rheumatoid arthritis (RA) with a number of genetic risk loci is well established; however, only part of the risk to develop the disease is based on…

read more
Get Clinical Tree app for offline access